Upsher-Smith is launching brimonidine tartrate and timolol maleate ophthalmic solution, 0.2%/0.5%, which is the generic of Allergan’s Combigan.
The eye drop is used to lower eye pressure in patients with open-angle glaucoma or high eye pressure (ocular hypertension) who require additional or adjunctive IOP-lowering therapy.
[Read more: Upsher-Smith opens manufacturing facility in Minnesota]
This product launch is a result of Upsher-Smith's strategic partnership with Rafarm UK, which includes developing and distributing six ophthalmic and otic ANDA products.
[Read more: Upsher-Smith extends fluoxetine product line]
The brimonidine tartrate and timolol maleate ophthalmic solution had a market value of approximately $392 million for the 12 months ending February 2023, per IQVIA.